STRIFON FORTE DSC Drug Patent Profile
✉ Email this page to a colleague
When do Strifon Forte Dsc patents expire, and when can generic versions of Strifon Forte Dsc launch?
Strifon Forte Dsc is a drug marketed by Ferndale Labs and is included in one NDA.
The generic ingredient in STRIFON FORTE DSC is chlorzoxazone. There are sixteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Strifon Forte Dsc
A generic version of STRIFON FORTE DSC was approved as chlorzoxazone by AUROBINDO PHARMA LTD on May 4th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for STRIFON FORTE DSC?
- What are the global sales for STRIFON FORTE DSC?
- What is Average Wholesale Price for STRIFON FORTE DSC?
Summary for STRIFON FORTE DSC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 137 |
| Patent Applications: | 3,588 |
| DailyMed Link: | STRIFON FORTE DSC at DailyMed |
US Patents and Regulatory Information for STRIFON FORTE DSC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferndale Labs | STRIFON FORTE DSC | chlorzoxazone | TABLET;ORAL | 081008-001 | Dec 23, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
